4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-26-009478
Chief Scientific Officer acquired 19,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kidron Miriam Chief Scientific Officer | 2026-01-22 | Option exercise | +19,000 | 1,448,664 | D | ||
| Derivatives | |||||||
| Kidron Miriam Chief Scientific Officer | 2026-01-22 | Option exercise · Performance Stock Units | −19,000 | 0 | D | ||
Loading xslF345X05/ownership.xml…